New Delhi: The National Institute of Pharmaceutical Education and Research, Raebareli, has signed a Memorandum of Understanding (MoU) with Roche Pharma India to promote academic collaboration and advance pharmaceutical education and research in India.
The MoU was signed at Shastri Bhawan, New Delhi, in the presence of Manoj Joshi, Secretary, Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers.
The partnership seeks to bridge the gap between academic learning and industry practices by providing students and faculty with practical exposure to the evolving pharmaceutical and regulatory landscape.
Under the agreement, the two institutions will jointly undertake several initiatives, including a certificate programme in regulatory affairs for students and industry professionals. The collaboration will also feature guest lecture series by industry experts, focusing on emerging areas such as AI-driven pharmaceutical research, drug development and healthcare innovation, aimed at enhancing industry-oriented knowledge and skills among students.
Speaking on the occasion, Joshi stressed the importance of strengthening India’s capabilities in regulatory sciences, biologics and artificial intelligence in pharmaceuticals to sustain global competitiveness. He noted that stronger partnerships between academia and industry would play a crucial role in achieving these goals and positioning India as a leader in advanced pharmaceutical innovation.
The collaboration aligns with the government’s broader development vision and initiatives such as #ViksitBharat and the BiopharmaShakti mission, which aim to transform India’s pharmaceutical sector from a volume-driven model to a value-driven innovation ecosystem.
The initiative is expected to contribute to the development of a future-ready workforce, while also supporting sustainable growth in India’s rapidly evolving life sciences and biopharmaceutical sector.
